<p> Nepheline syenite samples were collected from the Bancroft and Blue Mountain areas, Ontario, Canada, and were analysed for K, Rb, and Tl contents by atomic absorption spectrophotometry. The results for these elements and the corresponding K/Rb, K/Tl and Rb/Tl ratios were compared with those of nepheline syenites in various localities, and were found to be similar.</p> <p> The Tl, Rb, K contents and the K/Rb, K/Tl and Rb/Tl ratios in this study were determined to be 825 ppb, 110 ppm, 3.28%, 298, 4.11x10^4 and 135 respectively for the Bancroft nepheline syenite gneisses, and 574ppb, 93ppm, 3.28%, 353, 5.71x10^4 and 162 respectively for the Blue Mountain nepheline syenites. From these data, the nepheline syenite rocks in this study were probably originated as continental plutonics.</p> / Thesis / Bachelor of Science (BSc)

A tese objetivou beneficiar pacientes usuários de lítio por meio de dois estudos: (1) análise da bioequivalência de duas formulações de lítio; e (2) investigação do uso do lítio na pediatria. Para o estudo de bioequivalência, voluntários sadios (N=24) foram tratados com comprimidos (300mg) de carbonato de lítio de duas formulações: teste-Neurolithium e referência-Carbolitium. Após administrar cada formulação em períodos diferentes, foram coletadas amostras de plasma para quantificar íons lítio, utilizando espectrofotometria de absorção atômica. O método desenvolvido neste estudo apresentou limite de quantificação de 0,07mg/L. A média geométrica e o intervalo de confiança de 90% teste/referência foi de 104,77 (98,60-111,33%) para Cmax e 101,99 (96,81-107,44%) para ASClast. Seguindo os parâmetros propostos pelo FDA e ANVISA, concluiu-se que o Neurolithium é bioequivalente ao Carbolitium. Desta forma, este estudo assegura a comercialização de uma formulação de qualidade e o possível registro de um medicamento genérico com custo reduzido. O FDA não recomenda o uso de lítio em crianças menores de 12 anos, pois ainda não tem informações sobre segurança e eficácia da medicação nesses pacientes. Assim, o segundo estudo investigou o uso do lítio em pacientes pediátricos, divididos em dois grupos: (A) menores e (B) maiores de 12 anos. Pacientes que receberam prescrição de lítio no HC da Unicamp, entre 2000 e 2006, foram identificados e os prontuários médicos dos menores de 21 anos (N=77) foram revisados. Houve administração de menores doses nos pacientes do grupo A. Os níveis séricos e índice de efeitos colaterais não diferiram entre os grupos. O grupo A apresentou motivo de prescrição de lítio (agressividade) e eficácia (71%) diferentes do grupo B (alterações de humor; 83%). Uma vez que os índices de eficácia dos grupos foram condizentes com os da literatura e não houve diferença no aparecimento de efeitos colaterais, concluiu-se que é viável a utilização de lítio em menores de 12 anos. / The ideal of this thesis is to benefit patients that use lithium, through two studies: (1) comparison of the bioavailability of two lithium formulations; and (2) investigation of lithium use in children and adolescents. In order to analyze the bioequivalence, healthy volunteers (N=24), of both genders, were treated with two lithium carbonate formulations (300 mg): test ? Neurolithium and reference-Carbolitium. After administrate each formulation in separate periods, plasma samples were collected to quantify lithium, using atomic absorption spectrophotometry. The method was developed specially to this study and it showed 0,07mg/L quantification limit. The geometric media and the 90% confiance interval test/reference was 104,77 (98,60-111,33%) to Cmax and 101,99 (96,81-107,44%) to ASClast. Based on FDA and ANVISA parameters, we concluded that Neurolithium is bioequivalent to Carbolitium. Therefore, this study assures the commercialization of a qualified formulation and makes possible the register of a generic medication with low cost. Since information regarding the safety and effectiveness of lithium in children under 12 years of age is not available, its use in such patients is not recommended at this time. Therefore, the second study has investigated the use of lithium in pediatric patients, divided in two groups: (A) under and (B) over 12 years old. Patients that received lithium prescription inside of HC in Unicamp, between 2000 and 2006, were identified. Only clinical register of patients (N=77) under 21 years old, were revised. Fewer doses were administrated in group A. Seric levels and side effects indexes were not different between groups. Group A showed reason for lithium prescription (aggressiveness) and effectiveness (71%) different from group B (humor oscillation; 83%). Since indexes effectiveness from both groups were in accordance with those found in literature and there was no difference in side effects number per patient, we concluded that the use of lithium in patients under 12 years old is feasible.

<p> </p><p>Correlation between production method and mineral-, cadmium- and protein content were sought for Swedish winter wheat. The wheat was grown according to conventional, organic or biodynamic principles. The minerals; iron, zinc, magnesium, copper and the heavy metal cadmium were analyzed with atomic absorption spectroscopy. Protein was analyzed with elemental combustion analysis. All together, 17 samples were analyzed; nine from the still ongoing Bollerup field trial in Skåne and eight from four different farm pairs in the midst of Sweden.</p><p>The Bollerup field trials showed that organic wheat had a higher concentration of iron than conventional. Both organic and biodynamic wheat had a higher concentration of zinc than conventional. Magnesium concentration was higher in biodynamic wheat than in conventional grown wheat. Differences between production methods were in the range of 7.5 and 17%.</p><p>No unmistakable connections were found between any of the parameters and production method for the farm pairs. However, a tendency for more minerals in organic/biodynamic wheat was seen for all minerals but iron.</p><p>Due to unclean equipment, analyzing of cadmium contents could not be completed.</p>

Correlation between production method and mineral-, cadmium- and protein content were sought for Swedish winter wheat. The wheat was grown according to conventional, organic or biodynamic principles. The minerals; iron, zinc, magnesium, copper and the heavy metal cadmium were analyzed with atomic absorption spectroscopy. Protein was analyzed with elemental combustion analysis. All together, 17 samples were analyzed; nine from the still ongoing Bollerup field trial in Skåne and eight from four different farm pairs in the midst of Sweden. The Bollerup field trials showed that organic wheat had a higher concentration of iron than conventional. Both organic and biodynamic wheat had a higher concentration of zinc than conventional. Magnesium concentration was higher in biodynamic wheat than in conventional grown wheat. Differences between production methods were in the range of 7.5 and 17%. No unmistakable connections were found between any of the parameters and production method for the farm pairs. However, a tendency for more minerals in organic/biodynamic wheat was seen for all minerals but iron. Due to unclean equipment, analyzing of cadmium contents could not be completed.

A tese objetivou beneficiar pacientes usuários de lítio por meio de dois estudos: (1) análise da bioequivalência de duas formulações de lítio; e (2) investigação do uso do lítio na pediatria. Para o estudo de bioequivalência, voluntários sadios (N=24) foram tratados com comprimidos (300mg) de carbonato de lítio de duas formulações: teste-Neurolithium e referência-Carbolitium. Após administrar cada formulação em períodos diferentes, foram coletadas amostras de plasma para quantificar íons lítio, utilizando espectrofotometria de absorção atômica. O método desenvolvido neste estudo apresentou limite de quantificação de 0,07mg/L. A média geométrica e o intervalo de confiança de 90% teste/referência foi de 104,77 (98,60-111,33%) para Cmax e 101,99 (96,81-107,44%) para ASClast. Seguindo os parâmetros propostos pelo FDA e ANVISA, concluiu-se que o Neurolithium é bioequivalente ao Carbolitium. Desta forma, este estudo assegura a comercialização de uma formulação de qualidade e o possível registro de um medicamento genérico com custo reduzido. O FDA não recomenda o uso de lítio em crianças menores de 12 anos, pois ainda não tem informações sobre segurança e eficácia da medicação nesses pacientes. Assim, o segundo estudo investigou o uso do lítio em pacientes pediátricos, divididos em dois grupos: (A) menores e (B) maiores de 12 anos. Pacientes que receberam prescrição de lítio no HC da Unicamp, entre 2000 e 2006, foram identificados e os prontuários médicos dos menores de 21 anos (N=77) foram revisados. Houve administração de menores doses nos pacientes do grupo A. Os níveis séricos e índice de efeitos colaterais não diferiram entre os grupos. O grupo A apresentou motivo de prescrição de lítio (agressividade) e eficácia (71%) diferentes do grupo B (alterações de humor; 83%). Uma vez que os índices de eficácia dos grupos foram condizentes com os da literatura e não houve diferença no aparecimento de efeitos colaterais, concluiu-se que é viável a utilização de lítio em menores de 12 anos. / The ideal of this thesis is to benefit patients that use lithium, through two studies: (1) comparison of the bioavailability of two lithium formulations; and (2) investigation of lithium use in children and adolescents. In order to analyze the bioequivalence, healthy volunteers (N=24), of both genders, were treated with two lithium carbonate formulations (300 mg): test ? Neurolithium and reference-Carbolitium. After administrate each formulation in separate periods, plasma samples were collected to quantify lithium, using atomic absorption spectrophotometry. The method was developed specially to this study and it showed 0,07mg/L quantification limit. The geometric media and the 90% confiance interval test/reference was 104,77 (98,60-111,33%) to Cmax and 101,99 (96,81-107,44%) to ASClast. Based on FDA and ANVISA parameters, we concluded that Neurolithium is bioequivalent to Carbolitium. Therefore, this study assures the commercialization of a qualified formulation and makes possible the register of a generic medication with low cost. Since information regarding the safety and effectiveness of lithium in children under 12 years of age is not available, its use in such patients is not recommended at this time. Therefore, the second study has investigated the use of lithium in pediatric patients, divided in two groups: (A) under and (B) over 12 years old. Patients that received lithium prescription inside of HC in Unicamp, between 2000 and 2006, were identified. Only clinical register of patients (N=77) under 21 years old, were revised. Fewer doses were administrated in group A. Seric levels and side effects indexes were not different between groups. Group A showed reason for lithium prescription (aggressiveness) and effectiveness (71%) different from group B (humor oscillation; 83%). Since indexes effectiveness from both groups were in accordance with those found in literature and there was no difference in side effects number per patient, we concluded that the use of lithium in patients under 12 years old is feasible.

Detta examensarbete är en förundersökning till Glafos undersökning angående rening av glasbrukens processvatten från antimon med zeolit. Förundersökningen gick ut på att via experiment ta reda på hur mycket antimon som adsorberas av behandlad (för optimering: dels med NaNO3 och dels med NaCl) och obehandlad zeolit (porstorlek 0.4 nm). pH mättes och ställdes eftersom det har betydelse för adsorptionen, åtminstone vid väldigt lågt pH. När lösningarna hade filtrerats mättes den kvarvarande antimonhalten med atomabsorptionsspektrofotometri. Mätningarna visade att i genomsnitt 53 % av Sb-halten i lösningarna hade adsorberats av zeoliten. Förundersökningen visade att det inte blir någon adsorption då pH är väldigt lågt (under 1). Den visade också att när pH är över 4 verkar det inte ha någon betydelse om zeoliten är behandlad eller inte. Zeoliten bör behandlas med NaCl först i en tank med omrörning, sedan blandas i processvattnet (vars pH justerats till pH 4) i en tank eller bassäng och därefter filtreras. Tidsfaktorn för hur lång tid det tar för zeoliten att nå jämvikt och temperaturens inverkan bör även undersökas. / The aim of this diploma work is to study the removal of antimony from glassworks process water using zeolites. The experimental part of the studies were carried out to find the quantity of antimony adsorbed by the zeolite. The studies included treated (for optimization: partly with NaNO3 and partly with NaCl) and untreated zeolite. The pore size is 0.4 nm. pH was measured and adjusted because it is important for the antimony adsorption. When the solutions were filtrated the content of antimony left was measured with atomic absorption spectrophotometry. The measurements showed an average uptake of antimony by the zeolite of 53 %.The preinvestigation indicates that with a very low pH (below 1) there is no antimony adsorption. It also indicates that with pH above 4 it does not matter if the zeolite are treated or not. In further investigations the zeolite should be treated with NaCl in a stirred tank, then be mixed in the process water (pH is set to 4) in a tank or basin and then be filtrated. The time to reach equilibrium and the influence of temperature should also be investigated.

<p>Detta examensarbete är en förundersökning till Glafos undersökning angående rening av glasbrukens processvatten från antimon med zeolit.</p><p>Förundersökningen gick ut på att via experiment ta reda på hur mycket antimon som adsorberas av behandlad (för optimering: dels med NaNO3 och dels med NaCl) och obehandlad zeolit (porstorlek 0.4 nm). pH mättes och ställdes eftersom det har betydelse för adsorptionen, åtminstone vid väldigt lågt pH. När lösningarna hade filtrerats mättes den kvarvarande antimonhalten med atomabsorptionsspektrofotometri. Mätningarna visade att i genomsnitt 53 % av Sb-halten i lösningarna hade adsorberats av zeoliten. Förundersökningen visade att det inte blir någon adsorption då pH är väldigt lågt (under 1). Den visade också att när pH är över 4 verkar det inte ha någon betydelse om zeoliten är behandlad eller inte.</p><p>Zeoliten bör behandlas med NaCl först i en tank med omrörning, sedan blandas i processvattnet (vars pH justerats till pH 4) i en tank eller bassäng och därefter filtreras.</p><p>Tidsfaktorn för hur lång tid det tar för zeoliten att nå jämvikt och temperaturens inverkan bör även undersökas.</p> / <p>The aim of this diploma work is to study the removal of antimony from glassworks process water using zeolites.</p><p>The experimental part of the studies were carried out to find the quantity of antimony adsorbed by the zeolite. The studies included treated (for optimization: partly with NaNO3 and partly with NaCl) and untreated zeolite. The pore size is 0.4 nm. pH was measured and adjusted because it is important for the antimony adsorption. When the solutions were filtrated the content of antimony left was measured with atomic absorption spectrophotometry. The measurements showed an average uptake of antimony by the zeolite of 53 %.The preinvestigation indicates that with a very low pH (below 1) there is no antimony adsorption. It also indicates that with pH above 4 it does not matter if the zeolite are treated or not.</p><p>In further investigations the zeolite should be treated with NaCl in a stirred tank, then be mixed in the process water (pH is set to 4) in a tank or basin and then be filtrated.</p><p>The time to reach equilibrium and the influence of temperature should also be investigated.</p>

The coastal, indigenous communities around Alaska have subsisted on marine animals for generations, often focusing on large apex predators such as seals, sea lions, and whales. Three species of pinnipeds (harbor seal, Steller sea lion, northern fur seal) and the northern sea otter have all undergone significant population declines since the 1970s, some regions more than others. Archived vibrissae (whiskers) and body tissues from these four species were available from the Bering Sea and throughout the Gulf of Alaska from the 1990s and early 2000s. Tissues from these species are exceedingly difficult to obtain; thus, the archived tissues provided a finite and irreplaceable resource of data. Analysis of these archived tissues indicates which species, tissues, and gender bioaccumulate metals more readily. In this study twelve heavy metals (arsenic, cadmium, chromium, cobalt, copper, lead, manganese, mercury, nickel, selenium, vanadium, zinc) were analyzed in vibrissae from the four select species, and in body tissues from harbor seals and Steller sea lions. The samples were collected from three regions (southeastern, southcentral, and southwestern Alaska) during the 1990s through early 2000s. Significant differences of heavy metal concentrations in vibrissae were detected among elements (p2(110) = 454.81, p2(66) = 310.88, p